ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,555Hybrid

Journal of Neuroimmune Pharmacology

Acronym:jnip
•
Abbreviation (ISO):J. NEUROIMMUNE PHARMACOL
•
Identifier (ISSN):1557-1890(Print)/1557-1904(Online)
•
Publisher:Springer US
Clarivate IF (2026)
6.1↑ +2.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Neuroimmune Pharmacology

WoS Q1
257103.6620183.8720194.1120204.1520217.2920226.220235.220243.520256.12026
Annual Impact Factor Metric
Current (2026):6.1
Scopus SJR & RankScopus Q1
1.458
#2,555

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
99

99 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate1.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
60articles/year
37.37% Gold OA•88.24% Original Research

Aims & Scope

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

Topics Covered (Recognized by AI)
Medicine96.2%Biology96.1%Internal medicine86.8%Genetics78.6%Psychology73.3%Chemistry71.7%Immunology70.7%Biochemistry66.9%Neuroscience62.5%Pathology51.2%Endocrinology48.1%Psychiatry41%Pharmacology40.1%Disease39.9%Inflammation37.9%Receptor36.3%Immune system32.8%Cell biology30.8%Gene24.1%Virology21.8%Central nervous system20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

NEUROSCIENCES

Q1
Rank49/330
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank43/356
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q1
Rank48/330
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank44/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.1
Articles / Year39
Total Citations18
2025
IF3.5
Articles / Year106
Total Citations489
2024
IF5.2
Articles / Year61
Total Citations723
2023
IF6.2
Articles / Year39
Total Citations624
2022
IF7.285
Articles / Year18
Total Citations255

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,555Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineNeurosciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.458

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.07

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,523 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations797
3-Year Documents145
Citable Documents138

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Neuroscience (miscellaneous)Q1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Neuroimmune Pharmacology (acronym: jnip, abbr: J. NEUROIMMUNE PHARMACOL, ISSN: 1557-1890) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 2006. The periodical holds a Journal Impact Factor (JIF) of 6.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.458 (Q1), an H-index of 99.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 60 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,523 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Quarterly
Founding Year
2006
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 29417423-2bfe-4726-93f0-79557acdbf54
Database Updated: 2026-09-28